The indications for EPS differed according AP location but only for LL AP and NV AP location; patients with LL or NV AP were less frequently asymptomatic than patients with another AP location: the differences were highly significant for LL AP (0.0006 compared to AS AP, <0.0001 for RL AP and <0.0001 for PS AP).
← all excerpts
Age-related location of manifest accessory pathway and clinical consequences.
1
—
—